Sarepta Therapeutics (SRPT) Competitor Comparison
We are evaluating the key criteria listed to compare Sarepta Therapeutics (SRPT) against its competitors in the Biotechnology industry.
Market Capitalization
12 / 368Gross Profits
221 / 278Total Revenue
16 / 300EBITDA
311 / 337Free Cashflow
340 / 352Quick Ratio
195 / 357Earnings per Share
17 / 359Dividend yield
0 / 6Total Cash
11 / 358Performance 3 years
71 / 368Performance 5 years
109 / 368Performance 10 years
16 / 368Linearity 3 years
58 / 368Linearity 5 years
42 / 368Linearity 10 years
336 / 368Total Rank
354 / 368Dividend Rank
266 / 368Valuation Rank
304 / 368Piotroski Rank
312 / 368Muliplier Rank
200 / 368Dividend yield - SRPT ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.